文献速递痛风与晶体性关节病

急性焦磷酸钙晶体关节炎患者心血管事件风险研究

Risk of cardiovascular events in patients having had acute calcium pyrophosphate crystal arthritis.
PubMed 文献 · Ann Rheum Dis · 2022-08-11

基于Mass General Brigham电子健康记录1991-2017年的队列研究,将1200例急性焦磷酸钙晶体关节炎患者与3810例对照匹配,发现急性焦磷酸钙晶体关节炎与短期和长期非致死性心血管事件风险显著升高相关,主要不良心血管事件风险在0-2年显著升高,但死亡风险未显著升高。

要点

  • 急性焦磷酸钙晶体关节炎患者0-2年主要不良心血管事件发生率为91/1000人年,对照组为59/1000人年。
  • 0-2年主要不良心血管事件风险显著升高(HR 1.32,95%CI 1.01至1.73)。
  • 非致死性心血管事件在0-2年(HR 1.92,95%CI 1.12至3.28)和2-10年(HR 2.18,95%CI 1.27至3.75)均显著升高。

核心结论

  • 急性焦磷酸钙晶体关节炎与短期和长期非致死性心血管事件风险显著升高相关。

研究设计与样本

  • 队列研究,使用Mass General Brigham电子健康记录数据(1991-2017年),通过已发表的机器学习算法识别急性焦磷酸钙晶体关节炎患者(阳性预测值81%),对照按电子健康记录录入年份和索引日期匹配,共匹配1200例患者与3810例对照。

主要发现

  • 0-2年主要不良心血管事件发生率在急性焦磷酸钙晶体关节炎组为91/1000人年,对照组为59/1000人年;2-10年分别为58/1000人年和53/1000人年。
  • 急性焦磷酸钙晶体关节炎与0-2年主要不良心血管事件风险显著相关(HR 1.32,95%CI 1.01至1.73)。
  • 急性焦磷酸钙晶体关节炎与0-2年非致死性心血管事件风险显著相关(HR 1.92,95%CI 1.12至3.28),与2-10年非致死性心血管事件风险显著相关(HR 2.18,95%CI 1.27至3.75),但与死亡风险无显著关联。
  • 敏感性分析结果与主要分析相似;在仅门诊分析中,非致死性心血管事件风险在2-10年显著升高,但在0-2年未显著升高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Calcium pyrophosphate deposition (CPPD) disease, broadly defined, has been associated with increased risk of cardiovascular (CV) events. We investigated risk of CV events in patients with acute CPP crystal arthritis, the acute manifestation of CPPD. METHODS: Cohort study using Mass General Brigham electronic health record (EHR) data, 1991-2017. Patients with acute CPP crystal arthritis were identified using a published machine learning algorithm with positive predictive value 81%. Comparators were matched on year of EHR entry and index date of patients with acute CPP crystal arthritis (first positive synovial fluid CPP result or mention of 'pseudogout', or matched encounter). Major adverse cardiovascular event (MACE) was a composite of non-fatal CV event (myocardial infarction, acute coronary syndrome, coronary revascularisation, stroke) and death. We estimated incidence rates (IRs) and adjusted hazard ratios for MACE, non-fatal CV event and death, allowing for differential estimates during years 0-2 and 2-10. Sensitivity analyses included: (1) patients with acute CPP crystal arthritis diagnosed during outpatient visits, (2) patients with linked Medicare data, 2007-2016 and (3)patients matched on number of CV risk factors. RESULTS: We matched 1200 acute CPP crystal arthritis patients to 3810 comparators. IR for MACE in years 0-2 was 91/1000 person-years (p-y) in acute CPP crystal arthritis and 59/1000 p-y in comparators. In years 2-10, IR for MACE was 58/1000 p-y in acute CPP crystal arthritis and 53/1000 p-y in comparators. Acute CPP crystal arthritis was significantly associated with increased risk for MACE in years 0-2 (HR 1.32, 95% CI 1.01 to 1.73) and non-fatal CV event in years 0-2 (HR 1.92, 95% CI 1.12 to 3.28) and years 2-10 (HR 2.18, 95% CI 1.27 to 3.75), but not death. Results of sensitivity analyses were similar to the primary analysis; in the outpatient-only analysis, risk of non-fatal CVE was significantly elevated in years 2-10 but not in years 0-2. CONCLUSIONS: Acute CPP crystal arthritis was significantly associated with elevated short and long-term risk for non-fatal CV event.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Tedeschi SK, Huang W, Yoshida K, et al. Risk of cardiovascular events in patients having had acute calcium pyrophosphate crystal arthritis. Ann Rheum Dis. 2022. PMID: 35613842. doi:10.1136/annrheumdis-2022-222387

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。